Format

Send to

Choose Destination
See comment in PubMed Commons below
J Clin Psychiatry. 2008 Feb;69(2):e04.

Managing weight gain and metabolic issues in patients treated with atypical antipsychotics.

Author information

  • 1Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Mass., USA.

Abstract

The proven efficacy of second-generation antipsychotics (SGA) has led many clinicians to switch patients from a conventional antipsychotic to an SGA. However, SGAs may be associated with weight gain, dyslipidemia, high blood pressure, and ultimately with cardiovascular disease, diabetes, and metabolic syndrome. Clinicians should be aware of patients' individual risk factors for developing these illnesses and should carefully screen for changes in weight, body mass index, waist size, or lipid levels that could be potentially harmful and increase the risk for a more serious illness.

PMID:
18363448
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Physicians Postgraduate Press, Inc.
    Loading ...
    Write to the Help Desk